These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21029458)

  • 1. Resveratrol represses YKL-40 expression in human glioma U87 cells.
    Zhang W; Murao K; Zhang X; Matsumoto K; Diah S; Okada M; Miyake K; Kawai N; Fei Z; Tamiya T
    BMC Cancer; 2010 Oct; 10():593. PubMed ID: 21029458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between YKL-40 and adult primary astrocytoma.
    Zhang W; Kawanishi M; Miyake K; Kagawa M; Kawai N; Murao K; Nishiyama A; Fei Z; Zhang X; Tamiya T
    Cancer; 2010 Jun; 116(11):2688-97. PubMed ID: 20499402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein and mRNA levels of YKL-40 in high-grade glioma.
    Kazakova MH; Staneva DN; Koev IG; Staikov DG; Mateva N; Timonov PT; Miloshev GA; Sarafian VS
    Folia Biol (Praha); 2014; 60(6):261-7. PubMed ID: 25629266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tumor suppressor of resveratrol and prednisolone by downregulation of YKL-40 expression in CCRF-CEM cell line.
    Zadi Heydarabad M; Baharaghdam S; Azimi A; Mohammadi H; Eivazi Ziaei J; Yazdanpanah B; Zak MS; Farahani ME; Dohrabpour A; Partash N; Talebi M
    J Cell Biochem; 2019 Mar; 120(3):3773-3779. PubMed ID: 30426549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells.
    Junker N; Johansen JS; Hansen LT; Lund EL; Kristjansen PE
    Cancer Sci; 2005 Mar; 96(3):183-90. PubMed ID: 15771622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.
    Tanwar MK; Gilbert MR; Holland EC
    Cancer Res; 2002 Aug; 62(15):4364-8. PubMed ID: 12154041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways.
    Wang G; Dai F; Yu K; Jia Z; Zhang A; Huang Q; Kang C; Jiang H; Pu P
    Int J Oncol; 2015 Apr; 46(4):1739-47. PubMed ID: 25646654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitinase 3-like protein 2 (CHI3L2, YKL-39) activates phosphorylation of extracellular signal-regulated kinases ERK1/ERK2 in human embryonic kidney (HEK293) and human glioblastoma (U87 MG) cells.
    Areshkov PA; Kavsan VM
    Tsitol Genet; 2010; 44(1):3-9. PubMed ID: 20201406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A complex of nuclear factor I-X3 and STAT3 regulates astrocyte and glioma migration through the secreted glycoprotein YKL-40.
    Singh SK; Bhardwaj R; Wilczynska KM; Dumur CI; Kordula T
    J Biol Chem; 2011 Nov; 286(46):39893-903. PubMed ID: 21953450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
    Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
    Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
    Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
    J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.
    Ku BM; Lee YK; Ryu J; Jeong JY; Choi J; Eun KM; Shin HY; Kim DG; Hwang EM; Yoo JC; Park JY; Roh GS; Kim HJ; Cho GJ; Choi WS; Paek SH; Kang SS
    Int J Cancer; 2011 Mar; 128(6):1316-26. PubMed ID: 20506295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.
    Saidi A; Javerzat S; Bellahcène A; De Vos J; Bello L; Castronovo V; Deprez M; Loiseau H; Bikfalvi A; Hagedorn M
    Int J Cancer; 2008 May; 122(10):2187-98. PubMed ID: 18092325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway.
    Cilibrasi C; Riva G; Romano G; Cadamuro M; Bazzoni R; Butta V; Paoletta L; Dalprà L; Strazzabosco M; Lavitrano M; Giovannoni R; Bentivegna A
    PLoS One; 2017; 12(1):e0169854. PubMed ID: 28081224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers.
    Faibish M; Francescone R; Bentley B; Yan W; Shao R
    Mol Cancer Ther; 2011 May; 10(5):742-51. PubMed ID: 21357475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.
    Pelloski CE; Mahajan A; Maor M; Chang EL; Woo S; Gilbert M; Colman H; Yang H; Ledoux A; Blair H; Passe S; Jenkins RB; Aldape KD
    Clin Cancer Res; 2005 May; 11(9):3326-34. PubMed ID: 15867231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2.
    Bhat KP; Pelloski CE; Zhang Y; Kim SH; deLaCruz C; Rehli M; Aldape KD
    FEBS Lett; 2008 Sep; 582(21-22):3193-200. PubMed ID: 18708058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.
    Hormigo A; Gu B; Karimi S; Riedel E; Panageas KS; Edgar MA; Tanwar MK; Rao JS; Fleisher M; DeAngelis LM; Holland EC
    Clin Cancer Res; 2006 Oct; 12(19):5698-704. PubMed ID: 17020973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
    Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
    Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.